학술논문
A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib
Document Type
Article
Author
Source
In: JTO Clinical and Research Reports . (JTO Clinical and Research Reports, July 2022, 3(7))
Subject
Language
English
ISSN
26663643